Aligos Therapeutics, Inc. (ALGS) Net income 2019–2025
Aligos Therapeutics, Inc. (ALGS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.2MFY2025 · since FY2019: -$52.3M → -$24.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.2M | +81.6% |
| FY2024 | -$131.2M | -49.6% |
| FY2023 | -$87.7M | +8.7% |
| FY2022 | -$96.0M | +25.2% |
| FY2021 | -$128.3M | -18.2% |
| FY2020 | -$108.5M | -107.7% |
| FY2019 | -$52.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice